07:45 AM EDT, 07/30/2025 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) reported Q2 earnings Wednesday of $0.70 per diluted share, swinging from a loss of $0.45 a year earlier.

Analysts polled by FactSet expected a loss of $0.09.

Revenue for the quarter ended June 30 was $452 million, compared with $225 million a year earlier.

Analysts surveyed by FactSet expected $298.3 million.

For 2025, the company now expects revenue of between $825 million and $850 million, compared with the prior outlook of $725 million to $750

million. Analysts polled by FactSet expect $756.6 million.

Shares of the company rose more than 5% in recent premarket activity Wednesday.

Price: 43.61, Change: +2.13, Percent Change: +5.14